Tetra Bio-Pharma
$0
19
-$0-83.74% Friday 19:28
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
86,227.77
P/E Ratio
0
Dividend Yield
-
Dividend
-
Earnings
16OctExpected
Expected EPS
N/A
Actual EPS
-0.0064
Financials
-Profit Margin
Unprofitable0Revenue
-41.31MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow TBPMF. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Precious Metals
Pharmaceuticals: Other
Health Technology
Tetra Bio-Pharma Inc., a biopharmaceutical company, engages in the discovery and development of cannabinoid-derived drugs for inflammation, pain, ophthalmology, and oncology. The company develops PLENITUDE to treat cancer-related pain in advanced cancer patients; REBORN for the treatment of breakthrough cancer pain; Reduvo for chemotherapy-induced nausea and vomiting; ARDS-003 for the treatment of sepsis and prevention of acute respiratory distress syndrome; and SERENITY to treat cancer cachexia. It also develops PPP003 for painful dry eye and uveitis pain; and HCC011 for hepatocellular carcinoma. Tetra Bio-Pharma Inc. has an agreement with Cellvera Global Holdings LLC for the co-development of ARDS-003 as a combination product with Qifenda 400MG (Favipiravir), a commercial-stage broad-spectrum antiviral drug. The company is headquartered in Orléans, Canada.
Show more...
CEO
Dr. Guy Chamberland M.Sc., Master Herbal
Employees
33
Country
Canada
ISIN
CA88166Y1007
WKN
000A2ASQ8
Listings
0 Comments
Share your thoughts
FAQ
What is Tetra Bio-Pharma stock price today?▼
The current price of TBPMF is $0 USD — it has decreased by -83.74% in the past 24 hours. Watch Tetra Bio-Pharma stock price performance more closely on the chart.
What is Tetra Bio-Pharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Tetra Bio-Pharma stocks are traded under the ticker TBPMF.
What is Tetra Bio-Pharma market cap?▼
Today Tetra Bio-Pharma has the market capitalization of 86,227.77
What were Tetra Bio-Pharma earnings last quarter?▼
TBPMF earnings for the last quarter are -0.01 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Tetra Bio-Pharma revenue for the last year?▼
Tetra Bio-Pharma revenue for the last year amounts to 0 USD.
What is Tetra Bio-Pharma net income for the last year?▼
TBPMF net income for the last year is -41.31M USD.
How many employees does Tetra Bio-Pharma have?▼
As of May 06, 2026, the company has 33 employees.
In which sector is Tetra Bio-Pharma located?▼
Tetra Bio-Pharma operates in the Health & Wellness sector.
When did Tetra Bio-Pharma complete a stock split?▼
Tetra Bio-Pharma has not had any recent stock splits.
Where is Tetra Bio-Pharma headquartered?▼
Tetra Bio-Pharma is headquartered in Orléans, Canada.